Vasoactive responses of U46619, PGF2α, latanoprost, and travoprost in isolated porcine ciliary arteries

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 295-298

  Vysniauskiene, Ineta ^a   Allemann, Reto ^a   Flammer, Josef ^a   Haefliger, Ivan O ^a  

^a UNIVERSITY EYE CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11 FLUORO 9,15 DIHYDROXY 15 (2 INDANYL) 16,17,18,19,20 PENTANORPROSTA 5,13 DIENOIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; LATANOPROST; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN INHIBITOR; TRAVOPROST; UNCLASSIFIED DRUG; CLOPROSTENOL; DRUG DERIVATIVE; HYDRAZINE DERIVATIVE; PROSTAGLANDIN F; PROSTAGLANDIN RECEPTOR; THROMBOXANE RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; CILIARY ARTERY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG RESPONSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; PHYSIOLOGY; SWINE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CILIARY ARTERIES; CLOPROSTENOL; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRAZINES; PROSTAGLANDINS F, SYNTHETIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, THROMBOXANE; SWINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33644838934     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0760     Document Type: Article

References (17)

1. Coleman RA, Smith WL, Narumiya S. VIII. International Union of Pharmacology Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rew. 1994;46:205-229.
2. 2, F2alpha, and latanoprost acid on isolated ocular blood vessels in vitro. J Ocul Pharmacol Ther. 1998;14:119-128.
3. L-NAME and U 46619- induced contractions in isolated porcine ciliary arteries versus vortex veins. Klin Monatsbl Augenheilkd. 2001;218:366-369.
4. Hellberg MR, Salley VL, Mclaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther. 2001;17:421-432.
5. Haefliger IO, Flammer J, Lütscher T. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992;33:2340-2343.
6. Dettmann E, Vysniauskiene I, Wu R, Flammer J, Haefliger IO. Adrenomedullin-induced endothelium-dependent relaxation in porcine ciliary arteries. Invest Ophthalmol Vis Sci. 2003;44:3961-3966.
7. + channels. Invest Ophthalmol Vis Sci. 1997;38:1761-1767.
8. Hayashi E, Yoshitomi T, Ishikawa H, Hayashi R, Shimizu K. Effects of isopropyl unoprostone on rabbit ciliary artery. Jpn J Ophthalmol. 2000;44:214-220.
9. 2α response of isolated calf retinal resistance arteries. Exp Eye Res. 1989;48:329-335.
10. Ohkubo B, Chiba S. Vascular reactivities of simian ophthalmic and ciliary arteries. Curr Eye Res. 1987;6:1197-1204.
11. Brogiolo G, Flammer J, Haefliger IO. Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries. Klin Monatsbl Augenheilkd. 2001;218:373-375.
12. Sjoquist B, Stjernschantz J. Ocular and systemic pharmacokinetics of latanoprost in humans. Surv Ophthalmol. 2002;47(suppl 1):S6-S12.
13. Stjernschantz J, Selen G, Astin M, Resul B. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Prog Retin Eye Res. 2000;19:459-496.
14. Mitra M, Chang B, James T. Drug points: exacerbation of angina associated with latanoprost. BMJ. 2001;323:783.
15. 2α (FP) receptor. J Pharm Exp Ther. 1999;290:1278-1284.
16. Krauss AH, Woodward DF, Burk RM, et al. Pharmacological evidence for thromboxane receptor heterogeneity: implication for the eye. J Ocul Pharmacol Ther. 1997;13:303-312.
17. 1 and IP receptors. Br J Pharmacol. 2000;131:601-609.